The Bottom Line: Bayer pays the price for underestimating the U.S. court system

Bayer's stock price has plummeted after two costly verdicts in court cases involving Monsanto's Roundup weedkiller. Jim Gallagher and David Nicklaus agree that Bayer executives deserve the criticism they have faced for not understanding the potential liability.